José Roberto da Silva Junior

Dr. José Roberto da Silva Junior

Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
+2
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in Revista de Saúde Pública
Verified
Journal Article
Open access
PDF file
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
GSGustavo Fonseca Albuquerque Souza
Gustavo Fonseca Albuquerque Souza
GSGabriela Albuquerque Souza
Gabriela Albuquerque Souza
ACAna Lorena Nascimento Cordeiro
Ana Lorena Nascimento Cordeiro
GPGabriella Almeida Figueredo Praciano
Gabriella Almeida Figueredo Praciano
MSManuela Barbosa Rodrigues Souza
Manuela Barbosa Rodrigues Souza
OBJECTIVE: To estimate the prevalence of clinical signs and symptoms of severe/extreme stress, anxiety, and depression, as well as their associated factors, among Brazilians during social distancing. METHODS: This is a cross-sectional study conducted in April/May 2020 with 3,200 Brazilians over 18 years old. Respondents’ sociodemographic and clinical data were collected using an online questionnaire, which also included the 21-item Depression, Anxiety and Stress Scale (DASS-21) to assess emotional symptoms. Unadjusted and adjusted prevalence ratios and their respective 95% confidence intervals were estimated using Poisson regression models with robust variance. RESULTS: Our results show the prevalence of severe/extreme stress was 21.5%, anxiety 19.4%, and depression 21.5%. In the final model, sociodemographic, clinical, and Covid-19-related factors were associated with severe/extreme stress, anxiety, and depression in Brazilians during social distancing due to the Covid-19 pandemic. We found the main factors associated with severe/extreme depression to be young women, brown, single, not religious, sedentary, presenting reduced leisure activities, history of anxiety and depression, increased medication use, and Covid-19 symptoms. CONCLUSION: This study may help develop and systematically plan measures aimed to prevent, early identify, and properly manage clinical signs and symptoms of stress, anxiety, and depression during the Covid-19 pandemic. DESCRIPTORS: Mental Disorders, epidemiology. Stress, Psychological. Social Isolation. Coronavirus Infections. Health Surveys.

28 March 2015 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
IPIsabelle E A Pontes
Isabelle E A Pontes
KAKarine F Afra
Karine F Afra
José Roberto da Silva JuniorJosé Roberto da Silva Junior
José Roberto da Silva Junior
PBPaulo S N Borges
Paulo S N Borges
GCGeraldine F Clough
Geraldine F Clough
JAJoão G B Alves
João G B Alves
To compare microvascular reactivity assessed in the skin using laser Doppler fluximetry (LDF) in women with gestational diabetes mellitus (GDM) and gestational age-matched control during pregnancy. 110 pregnant women at ~33 weeks gestation participated in the study. Skin microvascular reactivity was evaluated by LDF, at rest, during the response to brief arterial occlusion (post occlusive hyperaemic response) and during sympathetically mediated vasoconstrictor response to deep inspiratory breath hold. No statistically significant differences were found in the microvascular variables studied (resting and maximum rate flux, post-ischaemic reactive hyperaemia and deep inspiratory breath holds) between +GDM and –GDM groups women. In women with GDM there was a negative correlation between resting flux and the response to the oral glucose tolerance test (OGTT), r = -0.282 (p = 0.037). There was also a negative correlation between the response to the OGTT and the sympathetically mediated constrictor response to inspiratory breath holds (r = -.298, p = .030) but not in women with GDM (r = .102, r = .468). Attenuated microvascular reactivity as an early marker of endothelial dysfunction is not present in women with GDM when assessed during pregnancy.

1 February 2021 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
GSGustavo Fonseca de Albuquerque Souza
Gustavo Fonseca de Albuquerque Souza
GPGabriella de Almeida Figueredo Praciano
Gabriella de Almeida Figueredo Praciano
ONOtávio da Cunha Ferreira Neto
Otávio da Cunha Ferreira Neto
MPMaria Carolina Paiva
Maria Carolina Paiva
RJRenata Patrícia Freitas Soares de Jesus
Renata Patrícia Freitas Soares de Jesus
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
Objectives: to determine the frequency and factors associated with severe / extreme signs and symptoms of stress, anxiety and depression in diabetic patients during the COVID-19 pandemic. Methods: cross-sectional study conducted in April /May 2020, which included 162 individuals with diabetes mellitus and over 18 years old. An online questionnaire was applied on social networks, composed of biological, sociodemographic, clinical characteristics and the Stress, Anxiety and Depression Scale (DASS-21). For statistical analysis, a multivariate logistic regression model was applied with a 5% significance level. Results: frequency of 37.7%, 43.3% and 45.1% were found for some symptom of stress, anxiety and depression, respectively. The factors associated with sign and symptoms of severe / extreme psychic disorders were: not having religion (stress, anxiety and depression); be at graduation (stress and anxiety); history of anxiety and depression (anxiety and depression); not practicing or decreasing physical exercises and starting, increased or continue taking sleeping medications (stress); history of contact with a suspected case of COVID-19, absence or decreased leisure (anxiety); female gender, absence of a partner, decreased family income and work or study (depression). Conclusion: the frequency of psychological disorders was higher than described in the literature on diabetic patients, being associated with biological, sociodemographic, clinical factors and aspects related to COVID-19 during the pandemic

10 April 2020 in Reproductive Health
Verified
Journal Article
Open access
PDF file
DGDaniele S. M. B. Gattás
Daniele S. M. B. Gattás
MAMelania M. R. de Amorim
Melania M. R. de Amorim
FFFrancisco E. L. Feitosa
Francisco E. L. Feitosa
José Roberto da Silva JuniorJosé Roberto da Silva Junior
José Roberto da Silva Junior
LRLívia C. G. Ribeiro
Lívia C. G. Ribeiro
Alex Sandro Rolland SouzaAlex Sandro Rolland Souza
Alex Sandro Rolland Souza
Background: Labor induction is defined as any procedure that stimulates uterine contractions before labor begins spontaneously. The vaginal and oral routes of administration of misoprostol are those most used for the induction of labor in routine practice, with the recommended dose being 25 μg. Nevertheless, the sublingual route may reduce the number of vaginal examinations required, increasing patient comfort and lowering the risk of maternal and fetal infection. Based on a previous systematic review, the objective of this study was to compare the frequency of tachysystole as the main outcome measure when misoprostol is administered sublingually at the dose of 12.5 μg versus vaginally at a dose of 25 μg to induce labor in a full-term pregnancy with a live fetus. Methods: A randomized, placebo-controlled, triple-blind clinical trial was conducted at two maternity hospitals in northeastern Brazil. Two hundred patients with a full-term pregnancy, a live fetus, Bishop score ≤ 6 and an indication for induction of labor were included. Following randomization, one group received 12.5 μg misoprostol sublingually and a vaginal placebo, while the other group received a sublingual placebo and 25 μg misoprostol vaginally. The primary outcome was the frequency of tachysystole. Student’s t-test, the chi-square test of association and Fisher’s exact test were used, as appropriate. Risk ratios and their 95% confidence intervals were calculated. Results: The frequency of tachysystole was lower in the group using 12.5 μg misoprostol sublingually compared to the group using 25 μg misoprostol vaginally (RR = 0.15; 95%CI: 0.02–0.97; p = 0.002). Failure to achieve vaginal delivery within 12 and 24 h was similar in both groups. Sublingual administration was preferred to vaginal administration by women in both groups; however, the difference was not statistically significant. Conclusion: The effectiveness of labor induction with low-dose sublingual misoprostol was similar to that achieved with vaginal administration of the recommended dose; however, the rate of tachysystole was lower in the sublingual group, and this route of administration may prove a safe alternative. Trial registration: Registration number: NCT01406392, ClinicalTrials.gov. Date of registration: August 1, 2011.

11 August 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
GCGuilherme Jorge Costa
Guilherme Jorge Costa
José Roberto da Silva JuniorJosé Roberto da Silva Junior
José Roberto da Silva Junior
CSCaio Cesar Arruda da Silva
Caio Cesar Arruda da Silva
TLTiago Pessoa Ferreira de Lima
Tiago Pessoa Ferreira de Lima
MCMariana Menezes Costa
Mariana Menezes Costa
MSMozart Júlio Tabosa Sales
Mozart Júlio Tabosa Sales
Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.

19 November 2013 in Trials
Verified
Journal Article
Open access
PDF file
José Roberto da Silva JuniorJosé Roberto da Silva Junior
José Roberto da Silva Junior
PBPaulo Sérgio Borges
Paulo Sérgio Borges
KAKarine F Agra
Karine F Agra
IPIsabelle Albuquerque Pontes
Isabelle Albuquerque Pontes
JAJoao Guilherme Alves
Joao Guilherme Alves
Gestational diabetes mellitus (GDM) is increasing worldwide and has been associated with adverse perinatal outcomes and high risk for chronic disease both for the mother and for the child. Physical exercise is feasible for diabetic pregnant women and contributes to better glycemic control and to a decrease in adverse perinatal outcomes. However, there are no randomized controlled trials (RCT) assessing the effects of aquatic physical exercise on GDM control and adverse maternal and fetal outcomes.